Redmile Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-882,814
Closed -$8.68M 88
2021
Q1
$8.68M Sell
882,814
-334,030
-27% -$2.75M 0.12% 75
2020
Q4
$5.42M Sell
1,216,844
-1,331,776
-52% -$6.03M 0.07% 78
2020
Q3
$11M Sell
2,548,620
-2,513,480
-50% -$17.9M 0.2% 69
2020
Q2
$44.9M Buy
+5,062,100
New +$25.6M 0.83% 37
2017
Q2
Sell
-1,019,491
Closed -$6.07M 66
2017
Q1
$6.07M Sell
1,019,491
-30,300
-3% -$146K 0.39% 51
2016
Q4
$4.15M Buy
+1,049,791
New +$7.69M 0.36% 41
2015
Q4
Sell
-724,348
Closed -$17.8M 61
2015
Q3
$17.8M Buy
+724,348
New +$20.5M 1.35% 23
2013
Q3
Sell
-5,000
Closed -$55K 55
2013
Q2
$55K Buy
+5,000
New +$105K 0.01% 49

Other funds holding DVAX

Redmile Group's DVAX Position: Q2 2021 in Review

Redmile Group sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 882,814 shares — an estimated $8.68M sold.

Redmile Group first reported a position in DVAX in Q2 2013 and held it in 8 quarters. The position peaked at $44.9M in Q2 2020. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • Redmile Group reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • Redmile Group sold 882,814 Dynavax Technologies shares in Q2 2021, an estimated $8.68M.
  • Redmile Group first reported a position in Dynavax Technologies in Q2 2013 and held it in 8 quarters.
  • Redmile Group's Dynavax Technologies position peaked at $44.9M in Q2 2020.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on Redmile Group's 13F filing for Q2 2021, filed 16 Aug 2021.